Jérôme Galon

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Jérôme Galon
Born (1967-02-06) February 6, 1967 (age 51)
Besançon, France
Nationality French
Citizenship France
Known for Work on immunology and cancer
Awards Award from Académie des sciences (2011),
Award from Académie de médecine (2011),
William B. Coley Award USA (2010)
Scientific career
Fields Immunology, Cancer
Institutions Pasteur Institute, Paris
Curie Institute, Paris
National Institute of Health (NIH), USA
INSERM

Jérôme Galon is a French biologist. He is first class Research Director (DR1) at Institut National de la Santé et de la Recherche Médicale (INSERM).

Education[edit]

Galon received his Ph.D. degree (Doctorat ès science) with specialty in immunology in 1996. and did postdoctoral work at the National Institute of Health (NIH), in Bethesda (USA) between 1997 and 2001. Since 2001, he has been working at the Cordeliers Research Center, where he has been the Director of the INSERM Laboratory Integrative Cancer Immunology since 2009. [1]

Scientific contributions[edit]

His work aims at a better understanding of the tumor microenvironment and the dynamics of the immune response in humans tumors. His laboratory has identified and demonstrated the importance of the immune contexture against cancer. He defined the Immunoscore as a new method for routine clinical assessment of prognosis of patients with cancer.

Awards and recognition[edit]

References[edit]

  • Galon J*, et al. "Towards the introduction of the Immunoscore in the classification of malignant tumors." J Pathol. 2013 Oct 3. doi: 10.1002/path.4287.
  • Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell HK, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J* "Spatio-temporal dynamics of intratumoral cells reveal the immune landscape in human cancer. Immunity. 2013 Oct 17;39(4):782-95.
  • Galon J*, Angell HK, Bedognetti D, and Marincola F. "The continuum of cancer immunosurveillance: prognostic, predictive and mechanistic signatures." Immunity. 2013 July 39(1), 11-26

External links[edit]